BALTIMORE, MD--(Marketwire - Dec 5, 2012) - Cere
Post# of 28539
Posted On: 12/05/2012 9:10:02 AM
BALTIMORE, MD--(Marketwire - Dec 5, 2012) - Cerecor Inc today announced that it has signed an option with Johns Hopkins University (JHU) for an exclusive license to develop and commercialize small molecule D-Amino Acid Oxidase inhibitors ("DAAO inhibitors") that were developed at the Johns Hopkins Brain Science Institute ("BSi").
View More
View More
(0)
(0)